Results From a Phase 3 Trial of Lynparza For Treating Ovarian Cancer Have Been Announced
Results from a Phase 3 trial of the medicine Lynparza (olaparib) for the treatment of advanced ovarian cancer in women with the BRCA-mutation have been announced as positive. The full…